VeriMom¿Debo evitar retinoyl tetrapeptide-43 amide durante el embarazo? | VeriMom
No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es retinoyl tetrapeptide-43 amide seguro durante el embarazo?
- No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
- ¿Es retinoyl tetrapeptide-43 amide seguro durante la lactancia?
- Same rationale as pregnancy: theoretical class-based concern due to retinoyl group but no specific reproductive or lactation transfer data. No regulatory harmonised flags or CIR/SCCS opinion for this ingredient. Expected topical absorption negligible, so low likelihood of significant transfer into breastmilk absent data.
- ¿Es retinoyl tetrapeptide-43 amide seguro para la piel del bebé?
- Hazard and mechanism remain theoretical (retinoid moiety) with no infant-specific data. Exposure increased by +1 relative to adult because infant skin has higher permeability and surface-area-to-weight, and although adult topical absorption is expected negligible, infant exposure is considered low but measurable in absence of definitive absorption data.
- ¿Cómo puntúa VeriMom a retinoyl tetrapeptide-43 amide?
- VeriMom puntúa retinoyl tetrapeptide-43 amide en 13/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a retinoyl tetrapeptide-43 amide en el embarazo?
- Consulta nuestra lista de alternativas seguras a retinoyl tetrapeptide-43 amide según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.